A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Boosting Bacteroides vulgatus in diabetic mice increased GLP-1 secretion, improving blood sugar control and reducing sugar ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

[1] In the presence of elevated glucose concentrations, GLP-1 and GIP increase insulin release and GLP-1 lowers glucagon secretion, thereby modulating the postmeal rise in glucose concentration ...

New Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

Several DPP-4 inhibitors are in clinical development; these are orally active and increase levels of active GLP-1, which in turn increases insulin secretion and reduces glucagon secretion and ...

This important study assessed the effects of food intake on sharp wave-ripples in the hippocampus of mice during subsequent sleep. Solid evidence supports the conclusion that sharp wave-ripples are ...

FGF21 is a mediator of the fasting response that increases glucose uptake, improves insulin sensitivity and reduces serum glucagon and triglyceride levels. In contrast to FGF19, FGF21 is not ...

Endocrinology is the branch of medicine that deals with disorders of the endocrine system. Genetic deletion of Kdm2a or pharmacological blockade of KDM2A, a histone 3 demethylase, in skeletal ...